Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2'-deoxyadenosine

British Journal of Haematology

Volumn 105, Issue 1, 1999, Pages 268-270

  Van Den Neste, E ^a   Louviaux, I ^a   Michaux, J L ^a   Delannoy, A ^b   Michaux, L ^a   Hagemeijer, A ^c   Scheiff, J M ^a   Bosly, A ^d   Straetmans, N ^a   Ferrant, A ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Hospital de Jolimont   (Belgium)

^c CENTER FOR HUMAN GENETICS   (Belgium)

^d UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

2 chloro 2' deoxyadenosine; Chronic lymphocytic leukaemia; Cladribine; Myelodysplastic syndrome; Secondary leukaemia

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CLADRIBINE; HEMOGLOBIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; PHORBOL 13 ACETATE 12 MYRISTATE; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CASE REPORT; CHROMOSOME 5; CHROMOSOME ANALYSIS; DRUG INDUCED CANCER; FEMALE; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRELEUKEMIA; PRIORITY JOURNAL; REFRACTORY ANEMIA; SECOND CANCER; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0032943423     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1999.01277.x     Document Type: Article

References (12)

1. Cheson, B.D. (1995) Infectious and immunosuppressive complications of purine analog therapy. Journal of Clinical Oncology, 13, 2431-2448.
2. Copplestone, J.A., Mufti, G.J., Hamblin, T.J. & Oscier D.G. (1986) Immunological abnormalities in myelodysplastic syndromecoexistent lymphoid or plasma cell neoplasms: a report of 20 cases unrelated to chemotherapy. British Journal of Haematology, 63, 149-159.
3. Frewin, R.J., Provan, D. & Smith, A.G. (1997) Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leukaemia. Clinical and Laboratory Haematology, 19, 151-152.
4. Kong, L.R., Huang, C.F., Hakimian, D., Variakojis, D., Klein, L., Kuzel, T.M., Gordon, L.I., Zanzig, C., Wollins, E. & Tallman, M.S. (1998) Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma. Cancer, 82, 957-964.
5. Kraut, E.H., Michael, R.G. & Bouroncle B.A. (1994) Long-term follow-up of patients with hairy cell leukaemia after treatment with 2′-deoxycoformycin. Blood, 84, 4061-4063.
6. Kroft, S.H., Tallman, M.S., Shaw, J.M., Thangavelu, M. & Peterson, L.C. (1997) Myelodysplasia following treatment of chronic lymphocytic leukemia with 2-chlorodeoxyadenosine (2-CdA). Leukemia, 11, 170.
7. Laurencet, F.M., Zulian, G.B., Cabrol, C. & Betticher, D.C. (1997) Myelodysplastic syndrome with biclonal monosomy 7 and trisomy 8 after treatment with cladribine (2-chloro-2-deoxyadenosine) and involved field radiation therapy. Cancer Genetics and Cytogenetics, 99, 85-89.
8. Orchard, J.A., Bolam, S. & Oscier, D.G. (1998) Association of myelodysplastic changes with purine analogues. British Journal of Haematology, 100, 677-679.
9. Pedersen-Bjergaard, J., Philip, P., Larsen, S.O., Andersson, M., Daugaard, G., Ersbdiameterll, J., Hansen, S.W., Hou-Jensen, K., Nielsen, D., Sigsgaard, T.C., Specht, L. & Osterlind, K. (1993) Therapy-related myelodysplasia and acute myeloid leukemia: cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia, 7, 1975-1986.
10. Robertson, L.E., Estey, E., Kantarjian, H., Koller, C., O'Brien, S., Brown, B. & Keating, M.J. (1994) Therapy related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia. Leukemia, 8, 2047-2051.
11. Schlaifer, D., Riga-Huguet, F., Pris, J., Brousset, P., Delannoy, A. & Bosly, A. (1994) Secondary neoplasms in two patients treated with purine analogues. Nouvelle Revue Française d'Hématologie, 36, 341.
12. Wells, S.J., Bray, R.A., Stempora, L.L. & Farhi, D.C. (1996) CD117/ CD34 expression in leukemic blasts. American Journal of Clinical Pathology, 106, 192-195.